Mindray's robust top-line growth encourages bullish '09 outlook
This article was originally published in Clinica
While the volatile economic climate has led many companies to take a more conservative approach in their earnings forecasts for 2009, Chinese medical device manufacturer Mindray Medical International is bucking the trend by confidently predicting double-digit growth for this year.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.